|
|
NARFE May
Together, we are making history in the fight against Alzheimer's disease! Clinical trial results for a drug called donanemab showed the strongest benefits of any Alzheimer's treatment research to date. And they provide hope — for those who could benefit and for all who join us in working toward a world without Alzheimer's and all other dementia. Thank you, NARFE members, for your help in this great accomplishment, for your contributions to our success in the past and for the achievements we will make together in the future.
|
|
|
Alzheimer's drug donanemab shows promising clinical trial results
Clinical trials results of the drug donanemab showed the treatment slowed progression of early symptomatic Alzheimer's disease. These results, the strongest Alzheimer's Phase 3 data released to date, underscore the call from the Alzheimer's Association for the Centers for Medicare & Medicaid Services to stop blocking access to Food and Drug Administration-approved treatments. Learn more.
|
|
|
|
Caregivers may have to assist with dental care
A person living with Alzheimer's or another dementia may forget how to brush his or her teeth. Caregivers may have to take a more hands-on approach, as proper oral care is necessary to prevent eating difficulties, digestive problems and infections. Learn more.
|
|
|
|
Long-distance Alzheimer's caregiving can be challenging
Many families are geographically spread apart and aren't always able to provide hands-on care for a person living with Alzheimer's or another dementia. Living at a distance can complicate caregiving, but our resources can help. Learn more.
|
|
|
|
Alzheimer's caregivers may experience depression
Caregiving for a person living with Alzheimer's is difficult and may lead to feelings of stress, guilt, anger, sadness, isolation and depression. If you're experiencing symptoms of depression, know that you aren't alone and that help is available. Learn more.
|
|
|
|
View Past Issues
|
|
|
|
NARFE 2025 Goal: $16 Million
|
|
|
24/7 Helpline: 1-800-272-3900
|
|